Melatonin prevents neutrophil-mediated oxidative injury in Escherichia coli-induced pyelonephritis in rats

Journal of Pineal Research

Volumn 41, Issue 3, 2006, Pages 220-227

  Şener, Göksel ^a   Tuǧtepe, Halil ^a   Velioǧlu Öǧünç, Ayliz ^a   Çetinel, Şule ^a   Gedik, Nursal ^a   Yeǧen, Berrak Ç ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

Antioxidants; Escherichia coli; Glutathione; Lipid peroxidation; Melatonin; Myeloperoxidase; Pyelonephritis; Tumor necrosis factor

Indexed keywords

COLLAGEN; CREATININE; GLUTATHIONE; LACTATE DEHYDROGENASE; MALONALDEHYDE; MELATONIN; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CHEMOLUMINESCENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; ESCHERICHIA COLI; FEMALE; HISTOPATHOLOGY; KIDNEY DYSFUNCTION; KIDNEY INJURY; KIDNEY PARENCHYMA; MALE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PYELONEPHRITIS; RAT; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; MALE; MELATONIN; NEUTROPHILS; OXIDATIVE STRESS; PYELONEPHRITIS; RATS; RATS, WISTAR;

EID: 33748369861     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2006.00357.x     Document Type: Article

References (44)

1. RUGO HS, O'HANLEY P, BISHOP AG et al. Local cytokine production in a murine model of Escherichia coli pyelonephritis. J Clin Invest 1992 March; 89:1032-1039.
2. MEYLAN PR, MARKERT M, BILLE J et al. Relationship between neutrophil-mediated oxidative injury during acute experimental pyelonephritis and chronic renal scarring. Infect Immunol 1989; 57:2196-2202.
3. ANDREOLI SP. Reactive oxygen molecules, oxidant injury and renal disease. Pediatr Nephrol 1991; 5:733-742.
4. BAUD L, NIVEZ MP, CHANSEL D et al. Stimulation by oxygen radicals of prostaglandin production by rat renal glomeruli. Kidney Int 1981; 20:34-42.
5. SHIHAMURA T. Mechanisms of renal tissue destruction in an experimental acute pyelonephritis. Exp Mol Pathol 1981; 34:34-42.
6. MONGA M, ROBERTS JA. The possible role of granulocyte elastase in renal damage from acute pyelonephritis. Pediatr Nephrol 1995; 9:583-586.
7. TAN DX, CHEN LD, POEGGELER B et al. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993; 1:57-60.
8. POEGGELER B, SAARELA S, REITER RJ et al. Melatonin - a highly potent endogenous radical scavenger and electron donor: new aspects of the oxidation chemistry of this indole accessed in vitro. Ann N Y Acad Sci 1994; 738:419-420.
9. PIERI C, MARRA M, MORONI F et al. Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci 1994; 55:PL271-PL276.
10. GILAD E, CUZZOCREA S, ZINGARELLI B et al. Melatonin is a scavenger of peroxynitrite. Life Sci 1997; 60:169-174.
11. TAN DX, POEGGELER B, REITER RJ. The pineal hormone melatonin inhibits DNA adduct formation induced by the chemical carcinogen safrole in vivo. Cancer Lett 1993; 70:65-71.
12. REITER RJ, TAN DX, ACUNA-CASTROVIEJO D et al. Melatonin: mechanisms and actions as an antioxidant. Curr Topics Biophys 2000; 24:171-183.
13. Reiter RJ, Tan DX, Manchester LC et al. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species. A review of the evidence. Cell Biochem Biophys 2001; 34:237-256.
14. WINIARSKA K, FRACZYK T, MALINSKA D, DROZAK J, BRYLA J. Melatonin attenuates diabetes-induced oxidative stress in rabbits. J Pineal Res 2006; 40:168-176.
15. KAVUKCU S, SOYLU A, TURKMEN M et al. The role of vitamin A in preventing renal scarring secondary to pyelonephritis. BJU Int 1999; 83:1055-1059.
16. TALKE H, SCHUBERT GE. Enzymatic urea determination in the blood and serum in the Warburg optical test. Klin Wochenschr 1965; 43:174-175.
17. SLOT C. Plasma creatinine determination. A new and specific Jaffe reaction method. Scand J Clin Lab Invest 1965; 17:381-387.
18. MARTINEK RG. A rapid ultraviolent spectrophotomeetric lactic dehydrogenase assay. Clin Chem Acta 1972; 40:91-99.
19. BEUGE JA, AUST SD. Microsomal lipid peroxidation. Methods Enzymol 1978; 53:302-311.
20. BEUTLER E. Glutathione in Red Blood Cell Metabolism A Manual of Biochemical Methods. Grune & Stratton, New York, 1975; pp. 137.
21. HILLEGAS LM, GRISWOLD DE, BRICKSON B et al. Assesment of myeloperoxidase activity in whole rat kidney. J Pharmacol Meth 1990; 24:285-295.
22. DAVIES GR, SIMMONDS NJ, STEVENS TR et al. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994; 35:179-185.
23. HAKLAR G, OZVERI ES, YUKSEL M, AKTAN AO, YALCIN AS. Different kinds of reactive oxygen and nitrogen species were detected in colon and breast tumors. Cancer Lett 2001; 165:219-224.
24. LOPEZ DE LEON A, ROJKIND M. A simple micromethod for collagen and total protein determination in formalin-fixed parraffin - embedded sections. J Histochem Cytochem 1985; 33:737-743.
25. ATKINS RC. The epidemiology of chronic kidney disease. Kidney Int 2005; 94(Suppl.):S14-S18.
26. GLAUSER MP, BILLE J, RANSLEY P. Urinary tract infections, pyelonephritic scars and chemotherapy. In: Experimental Models in Antimicrobial Chemotherapy. Zak O, Sande MA, eds. Academic Press Inc. London Ltd, London, 1986; pp. 319-345.
27. BROOKS SJD, LYONS JM, BRAUDE AI. Immunization against retrograde pyelonephritis. I. Production of an experimental model of severe ascending Escherichia coli pyelonephritis without bacteremia in rats. Am J Pathol 1974; 74:345-358.
28. BROOKS SJD, LYONS JM, BRAUDE AI. Immunization against retrograde pyelonephritis III. Vaccination against chronic pyelonephritis due to E. Coli. J Infect Dis 1974; 136:633-639.
29. MEYLAN PR, GLAUSER MP. Failure of dexamethasone to prevent polymorphonuclear leukocyte infiltration during experimental acute exudative pyelonephritis and to reduce subsequent chronic scarring. J Infect Dis 1988; 157:480-485.
30. KLEBANOFF SJ. Myeloperoxidase: contribution to the microbicidal activity of intact leukocytes. Science 1970; 169:1095-1097.
31. PRYOR WA. Oxy-radicals and related species: their formation, lifetimes, and reactions. Annu Rev Physiol 1986; 48:657-667.
32. Garcia JJ, Reiter RJ, Ortiz GG et al. Melatonin enhances tamoksifen's abilityt to prevent the reduction in microsomal membrane fluidity induced by lipid peroxidation. J Membr Biol 1998; 162:59-65.
33. PIERREFICHE G, TOPALL G, COURBOIN G, HENRIET I, LABORIT H. Antioxidant activity of melatonin in mice. Res Commun Chem Pathol Pharmacol 1993; 80:211-223.
34. GARCIA JJ, REITER RJ, GUERRERO JM et al. Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett 1997; 408:297-300.
35. RODRIGUEZ C, MAYO JC, SAINZ RM et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36:1-9.
36. TOMAS-ZAPICO C, COTO-MONTES A. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J Pineal Res 2005; 39:99-104.
37. ROSS D. Glutathione, free radicals and chemotherapeutic agents. Pharmacol Ther 1988; 37:231-249.
38. WINTERBOURN CC. Free radical toxicology and antioxidant defence. Clin Exp Pharmacol Physiol 1995; 22:877-880.
39. WOLIN MS, AHMAD M, GUPTE SA. Oxidant and redox signaling in vascular oxygen sensing mechanisms: basic concepts, current controversies, and potential importance of cytosolic NADPH. Am J Physiol Lung Cell Mol Physiol 2005; 289:L159-L173.
40. HOUSTON MC. Nutraceuticals, vitamins, antioxidants, and minerals in the prevention and treatment of hypertension. Prog Cardiovasc Dis 2005; 47:396-449.
41. HIMMELFARB J. Relevance of oxidative pathways in the pathophysiology of chronic kidney disease. Cardiol Clin 2005; 23:319-330.
42. BENNETT RT, MAZZACCARO RJ, CHOPRA N, MELMAN A, FRANCO I. Suppression of renal inflammation with vitamins A and E in ascending pyelonephritis in rats. J Urol 1999; 161:1681-1684.
43. POLI G, PAROLA M. Oxidative damage and fibrogenesis. Free Radic Biol Med 1997; 22:287-305.
44. BILLE J, GLAUSER MP. Protection against chronic pyelonephritis in rats by suppression of acute suppuration: effects of colchicine and neutropenia. J Infect Dis 1982; 146:220-226.